Catalyst Wire Dossier Catalyst Wire Dossier

XENOVIEW

XENON XE 129 HYPERPOLARIZED · Polarean, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XENOVIEW, covering 2022-12-23 to 2025-05-30. Get the full timeline:

Most recent: FDA Approved: XENOVIEW — Supplemental Application (Polarean, Inc.)

See pricing